In vitro studies have shown that rifampicin inhibits ATX expression in human HepG2 hepatoma cells and in hepatoma cells overexpressing the PXR, but not in hepatoma cells in which PXR has been knocked down. This evidence concerns the gene ENPP2 and hepatocellular carcinoma.